Clinical trial / 1993
Aspartame challenge was linked to adverse symptoms in individuals with depression
In a crossover study, participants received 30 mg/kg/day of aspartame or placebo across 7-day periods. The trial was halted after 13 individuals completed the protocol due to severe reactions among participants with depression history. In these patients, aspartame was linked to significantly greater symptom frequency and severity compared to placebo. No difference was observed among individuals without a psychiatric history.
- Study type
- Double-blind crossover study
- Who was studied
- 13 individuals with unipolar depression or no psychiatric history
- What was measured
- Frequency and severity of adverse symptoms
THE PAPER
Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population.
Walton RG, Hudak R, Green-Waite RJ. Biol Psychiatry, 1993.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.